Note: Ingredients listed on restricted chemical lists
EC/CAS
231-633-2/7664-38-2
Name of the chemical
phosphoric acid
Concentration
≤5
EC/CAS
215-647-6/1336-21-6
Name of the chemical
ammonium hydroxide
Concentration
<1
General Information
Version
3
Revision date
2021-05-06
Product name
INTERPLUS 4101 CLEAN GEL
1.2.1 Relevant identified uses
Professional application of coatings and inks
1.2.2. Uses advised against
Reason
Emergency telephone
+46 (0) 31 928500, +46 (0) 31 928530, +44 (0)344 892 0111, +353 (0)1 809 2566, +46 8 33 12 31
Icons in SDS
Company Information
company name
International Farg AB
e-mail address of the competent person responsible for the Safety Data Sheet
sdsfellinguk@akzonobel.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H319
Hazard statements
Code
Statements
H319
Causes serious eye irritation
Section 2
SECTION 2: Hazards identification
1272/2008] Classification of the substance or mixture
Product definition
Mixture
Signal word
Warning
Hazard statements
Causes serious eye irritation.
Precautionary statements
General Not applicable.
Prevention
Wear eye or face protection. Wash hands thoroughly after handling.
Response
IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists: Get medical attention.
Storage
Not applicable.
Disposal
Dispose of contents and container in accordance with all local, regional, national and international regulations.
Supplemental label elements
elements Wear appropriate respirator when ventilation is inadequate.
Annex XVII - Restrictions on the manufacture, placing on the market and use of certain dangerous substances, mixtures and articles
Not applicable.
Other hazards which do not result in classification
None known.
2.1 Classification of the substance or mixture
Product definition : Mixture Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS] Eye Irrit. 2, H319 The product is classified as hazardous according to Regulation (EC) 1272/2008 as amended. See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.
